NCT00677313 An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy Status COMPLETED Phase NA
NCT00673738 Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) Status COMPLETED Phase PHASE2
NCT00673231 Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin Status COMPLETED Phase PHASE3
NCT00672009 A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer Status TERMINATED Phase PHASE2
NCT00670189 A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00666458 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D) Status COMPLETED Phase PHASE3
NCT00665444 Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder Status TERMINATED Phase NA
NCT00664625 A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT00663702 Phase IIIB Switching From Intravenous to Subcutaneous Study Status COMPLETED Phase PHASE3
NCT00663260 Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Status COMPLETED Phase PHASE2/PHASE3
NCT00663208 A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects Status COMPLETED Phase PHASE2
NCT00662545 Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection Status COMPLETED Phase PHASE4
NCT00661362 Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00656890 A Study of MDX-1100 in Subjects With Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00656734 Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. Status COMPLETED Phase PHASE1
NCT00655746 The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00651508 Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00648453 Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function Status COMPLETED Phase PHASE4